Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Chabner

Showing results (121-130 of 245) with videos related to

Pageof 25
Sort By:
Seminars in Oncology|September 1, 1980
Staging of non-Hodgkin's lymphomaB A Chabner, R I Fisher, R C Young, et al.
Biochemical Pharmacology|March 16, 2010
Cytidine and deoxycytidylate deaminase inhibition by uridine analogsJ C Drake, K R Hande, R W Fuller, et al.
The New England Journal of Medicine|August 24, 1972
Late recurrence of testicular tumorB A Chabner, G P Canellos, C L Olweny, et al.
Lancet (London, England)|February 22, 1975
Letter: Altered plasma pharmacokinetics of methotrexate administered intrathecallyS A Jacobs, W A Bleyer, B A Chabner, et al.
Medicine|January 1, 1979
The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literatureG Y Locker, J H Doroshow, L A Zwelling, et al.
Clinical Pharmacology and Therapeutics|December 1, 1983
Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinolS Zimm, J M Collins, D O'Neill, et al.
Blood|August 1, 1974
Bone marrow involvement in Hodgkin's disease: pathology and response to MOPP chemotherapyC E Myers, B A Chabner, V T De Vita, et al.
Journal of the National Cancer Institute|February 1, 1982
Phase I-phase II trial of N-phosphonacetyl-L-aspartic acid given by intravenous infusion and 5-fluorouracil given by bolus injectionC Erlichman, R C Donehower, J L Speyer, et al.
Drug Metabolism Reviews|January 1, 1978
Methotrexate disposition in humans: case studies in ovarian cancer and following high-dose infusionB A Chabner, R G Stoller, K Hande, et al.
Cancer Research|September 1, 1978
Reversibility of high-affinity binding of methotrexate in L1210 murine leukemia cellsM Cohen, R A Bender, R Donehower, et al.
Pageof 25

Showing results (121-130 of 245) with videos related to

Sort By:
Pageof 25
Seminars in Oncology|September 1, 1980
Staging of non-Hodgkin's lymphomaB A Chabner, R I Fisher, R C Young, et al.
Biochemical Pharmacology|March 16, 2010
Cytidine and deoxycytidylate deaminase inhibition by uridine analogsJ C Drake, K R Hande, R W Fuller, et al.
The New England Journal of Medicine|August 24, 1972
Late recurrence of testicular tumorB A Chabner, G P Canellos, C L Olweny, et al.
Lancet (London, England)|February 22, 1975
Letter: Altered plasma pharmacokinetics of methotrexate administered intrathecallyS A Jacobs, W A Bleyer, B A Chabner, et al.
Medicine|January 1, 1979
The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literatureG Y Locker, J H Doroshow, L A Zwelling, et al.
Clinical Pharmacology and Therapeutics|December 1, 1983
Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinolS Zimm, J M Collins, D O'Neill, et al.
Blood|August 1, 1974
Bone marrow involvement in Hodgkin's disease: pathology and response to MOPP chemotherapyC E Myers, B A Chabner, V T De Vita, et al.
Journal of the National Cancer Institute|February 1, 1982
Phase I-phase II trial of N-phosphonacetyl-L-aspartic acid given by intravenous infusion and 5-fluorouracil given by bolus injectionC Erlichman, R C Donehower, J L Speyer, et al.
Drug Metabolism Reviews|January 1, 1978
Methotrexate disposition in humans: case studies in ovarian cancer and following high-dose infusionB A Chabner, R G Stoller, K Hande, et al.
Cancer Research|September 1, 1978
Reversibility of high-affinity binding of methotrexate in L1210 murine leukemia cellsM Cohen, R A Bender, R Donehower, et al.
Pageof 25